A detailed history of Goldman Sachs Group Inc transactions in Legend Biotech Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 456,944 shares of LEGN stock, worth $18.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
456,944
Previous 667,990 31.59%
Holding current value
$18.7 Million
Previous $29.6 Million 24.74%
% of portfolio
0.0%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$43.55 - $59.88 $9.19 Million - $12.6 Million
-211,046 Reduced 31.59%
456,944 $22.3 Million
Q2 2024

Aug 13, 2024

BUY
$39.5 - $57.22 $14.1 Million - $20.5 Million
357,582 Added 115.2%
667,990 $29.6 Million
Q1 2024

May 15, 2024

SELL
$55.06 - $69.99 $11.7 Million - $14.9 Million
-212,259 Reduced 40.61%
310,408 $17.4 Million
Q4 2023

Feb 13, 2024

BUY
$57.25 - $69.74 $14.9 Million - $18.2 Million
260,899 Added 99.67%
522,667 $31.4 Million
Q3 2023

May 14, 2024

SELL
$63.16 - $76.5 $16.5 Million - $20 Million
-260,899 Reduced 49.92%
261,768 $17.6 Million
Q3 2023

Nov 14, 2023

SELL
$63.16 - $76.5 $8.05 Million - $9.75 Million
-127,433 Reduced 32.74%
261,768 $17.6 Million
Q2 2023

May 14, 2024

BUY
$46.28 - $75.01 $6.17 Million - $9.99 Million
133,215 Added 52.04%
389,201 $26.9 Million
Q2 2023

Aug 14, 2023

BUY
$46.28 - $75.01 $6.17 Million - $9.99 Million
133,215 Added 52.04%
389,201 $26.9 Million
Q1 2023

May 14, 2024

BUY
$43.42 - $57.37 $2.15 Million - $2.84 Million
49,583 Added 24.02%
255,986 $12.3 Million
Q1 2023

May 11, 2023

BUY
$43.42 - $57.37 $2.15 Million - $2.84 Million
49,583 Added 24.02%
255,986 $12.3 Million
Q4 2022

May 14, 2024

SELL
$38.8 - $55.46 $13.6 Million - $19.4 Million
-350,255 Reduced 62.92%
206,403 $10.3 Million
Q4 2022

Feb 13, 2023

SELL
$38.8 - $55.46 $13.6 Million - $19.4 Million
-350,255 Reduced 62.92%
206,403 $10.3 Million
Q3 2022

May 14, 2024

BUY
$38.15 - $57.1 $5.28 Million - $7.9 Million
138,330 Added 33.07%
556,658 $22.7 Million
Q3 2022

Nov 10, 2022

BUY
$38.15 - $57.1 $5.28 Million - $7.9 Million
138,330 Added 33.07%
556,658 $22.7 Million
Q2 2022

May 14, 2024

SELL
$33.54 - $55.0 $3.5 Million - $5.74 Million
-104,339 Reduced 19.96%
418,328 $23 Million
Q2 2022

Aug 15, 2022

BUY
$33.54 - $55.0 $1.73 Million - $2.83 Million
51,464 Added 14.03%
418,328 $23 Million
Q1 2022

May 16, 2022

BUY
$31.02 - $48.18 $4.59 Million - $7.12 Million
147,830 Added 67.49%
366,864 $13.3 Million
Q4 2021

Feb 14, 2022

BUY
$41.14 - $56.98 $5.93 Million - $8.22 Million
144,190 Added 192.65%
219,034 $10.2 Million
Q3 2021

Nov 10, 2021

BUY
$35.31 - $50.56 $2.64 Million - $3.78 Million
74,844 New
74,844 $3.78 Million

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.85B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.